Concepedia

Massimo Lopez

ML

40

Publications

2.5K

Citations

22

H-Index

1982

Active since

Affiliations

Tumori Foundation(Current)

Instituto Nazionale Tumori Regina Elena

La Maddalena

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Massimo Lopez is an author at Tumori Foundation specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1982–2011

40

Publications

40

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Giuseppe Colucci, Vittorio Gebbia, G Paoletti et al. · Journal of Clinical Oncology · 2005 · 775 citations

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.

Giuseppe Colucci, Francesco Giuliani, Vittorio Gebbia et al. · PubMed · 2002 · 385 citations

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma

Giuseppe Colucci, Francesco Giuliani, Vittorio Gebbia et al. · Cancer · 2002 · 280 citations

, , +12

Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide

Paola Papaldo, Massimo Lopez, Paolo Marolla et al. · Journal of Clinical Oncology · 2005 · 96 citations · Full text

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Paola Papaldo, Massimo Lopez, Enrico Cortesi et al. · Journal of Clinical Oncology · 2003 · 74 citations

Rows per page

1–5 of 40